Search clinical trials for: Sodium-glucose cotransporter 2 inhibitor
Total 9212 results
-
Taipei Medical University WanFang HospitalUnknown
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
The George InstituteMonash University; University of Sydney; The University of New South WalesRecruitingType 2 DiabetesAustralia
-
Icahn School of Medicine at Mount SinaiRecruitingHeart Failure With Reduced Ejection Fraction | CongestionUnited States
-
University of California, San FranciscoRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AgelessRxEnrolling by invitation
-
The University of Texas Health Science Center at...AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
University Health Network, TorontoMerck Sharp & Dohme LLC; University Medical Center Groningen; University of Toronto and other collaboratorsCompletedHeart Failure | Type 2 Diabetes MellitusNetherlands, Canada
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
RWTH Aachen UniversityBoehringer IngelheimTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
National Medical Research Center for Cardiology...Ministry of Health of the Russian FederationCompletedDiabetes Mellitus, Type 2 | Heart Failure, DiastolicRussian Federation
-
AstraZenecaCompletedHeart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, Korea, Republic of, Brazil, Slovakia, Japan, South Africa, Sweden
-
Steno Diabetes Center CopenhagenNovo Nordisk A/S; Glostrup University Hospital, CopenhagenCompletedHypoxia | Type 1 Diabetes | Nephropathy | Autonomic Neuropathy, Diabetic | Mitochondrial AlterationDenmark
-
Novartis PharmaceuticalsCompletedElevated Body Mass IndexUnited States
-
Baylor College of MedicineTerminatedType 2 Diabetes MellitusUnited States
-
Hellenic Society for Medical EducationTerminated
-
University of DundeeAstraZeneca; NHS TaysideCompletedDoes Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? (DAPA-LVH)Type 2 Diabetes | Left Ventricular HypertrophyUnited Kingdom
-
Christopher BellAstraZenecaCompletedPhysical ActivityUnited States
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus | Renal Impairment
-
Hamad Medical CorporationUnknownMyocardial Infarction | PreDiabetes | CVD | T2DM (Type 2 Diabetes Mellitus)Qatar
-
University of Erlangen-Nürnberg Medical SchoolCompletedDiabetes Mellitus Type 2Germany
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States
-
Astellas Pharma IncCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHealthy | Diabetes Mellitus, Type 2United States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 1Canada
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Bioavailability of IpragliflozinUnited Kingdom
-
Astellas Pharma IncCompleted
-
Beijing Anzhen HospitalRecruitingCoronary Artery Disease | Diabete MellitusChina
-
Sequana Medical N.V.Active, not recruitingHeart Failure | Volume OverloadGeorgia
-
Nanjing University School of MedicineRecruiting
-
Shahid Beheshti University of Medical SciencesRecruitingHeart Failure | HemodialysisIran, Islamic Republic of
-
Dong-A ST Co., Ltd.Recruiting
-
Monaldi HospitalRecruitingEfficacy | Systemic Right Ventricle | Dapagliflozin Adverse ReactionItaly
-
University of MilanNot yet recruiting
-
G.Gennimatas General Hospital2nd Department of Cardiology, "Attikon" University Hospital, National and...Not yet recruitingAcute Kidney Injury | Percutaneous Coronary Intervention | Left Cardiac Catheterization | Sodium-glucose Co-transporter 2 InhibitorsGreece
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingType2 Diabetes | Insulin SensitivityUnited States
-
Spanish Society of CardiologyFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIActive, not recruitingAortic Stenosis | Transcatether Aortic Valve ImplantationSpain
-
Boehringer IngelheimActive, not recruitingHeart FailureCzechia, Switzerland, Poland, Hungary, Romania, Bulgaria
-
University of WashingtonAstraZenecaCompletedMyocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial InflammationUnited States
-
Hospices Civils de LyonWithdrawnEnd-stage Heart FailureFrance
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Boehringer IngelheimCompleted